Patents by Inventor Jose Castell

Jose Castell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12006311
    Abstract: The present invention relates to compounds of formula (I) for use in preventing and/or treating cancer.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: June 11, 2024
    Assignees: FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRONINSTITUT DE RECERCA, INSTITUT UNIV. DE CIÈNCIA I TECNOLOGIA, S. A.
    Inventors: Josep Roma Castanyer, Marta Pascual Gilabert, José Sánchez De Toledo Codina, Soledad Gallego Melcón, Patricia Zarzosa Martínez, Javier Alonso Fernández, Sergio Pérez Ozcáriz, Cristina López Gómez, Josep Castells Boliart
  • Publication number: 20050224200
    Abstract: The invention comprises a method to increase the water absorption of tissue paper towel products by incorporating super-absorbent polymers (SAP) in between the laminated tissue plies. The SAP is dosed in selected places in the tissue towel manufacturing process without the need to substantially change the current converting or manufacturing process, or the major equipment that is used or the properties of the base sheet tissue paper.
    Type: Application
    Filed: April 7, 2004
    Publication date: October 13, 2005
    Inventors: Robert Bouchard, Marc Desaulniers, Jose Castell, Vincent Landry, Wladimir Janssen
  • Publication number: 20050176147
    Abstract: A cell model is disclosed that has a phenotypic profile, expressing at least one drug biotransformation enzyme. This model includes a cell having cytochrome reductase activity, transformed with at least one expression vector comprising a DNA sequence for a drug biotransformation enzyme. The method is based on the use of expression vectors coding for the sense and anti-sense mRNA of the Phase I and Phase II drug biotransformation enzymes showing a greatest variability in humans for transforming cells expressing cytochrome reductase activity. Such vectors can modulate (increase or decrease) the individualised expression of an enzyme without affecting the other enzymes. This cell model can reproduce in vitro the metabolic idiosyncrasy of humans. It is applicable in the study of development of new drugs, specifically in the study of metabolism, potential idiosyncratic hepatotoxicity, medicament interactions, etc., of new drugs.
    Type: Application
    Filed: February 10, 2004
    Publication date: August 11, 2005
    Applicant: ADVANCED IN VITRO CELL TECHNOLOGIES, S.L.
    Inventors: Jose Castell Ripoll, Ramiro Atienza, Maria Gomez Lechon